Quick Takeaways: Why It Matters? The EUA makes ivermectin liquid a short-term, horse-only screwworm prophylaxis tool, adding another regulated option to the NWS armamentarium and slightly strengthening biosecurity for foals and wounded horses, but because protection lasts only 24 hours and...
Quick Takeaways: Why It Matters? By bringing real-time, cellular-level microscopic imaging into everyday veterinary workflows, without lab delays, InSpecta gives specialist, general, and mobile practices a new in‑house diagnostic capability that can speed decision-making and create billabl...
Quick Takeaways: Why It Matters? Full FDA approval for Laverdia transforms it from a conditionally approved option into the first fully approved oral, at‑home standard therapy for canine lymphoma, which should significantly boost veterinarian confidence and utilization via Dechra’s nationa...
Quick Takeaways: Why It Matters? Jaguar’s NADA submission is a meaningful de-risking step for Canalevia-CA1, because full FDA approval would likely expand its commercial credibility beyond conditional use and make it easier to gain adoption in veterinary onc...
Quick Takeaways: Why It Matters? With both TAS and RXE accepted, Loyal moves significantly closer to commercializing the first true longevity drug in veterinary medicine, turning canine lifespan extension into a near-term, rather than speculative, market. If LOY-002 reache...
